p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer's Disease Research, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how p-Tau 205 and p-Tau 212 may advance Alzheimer's disease diagnosis and biomarker precision. Attendees will gain insight into how these markers compare with and complement existing p-Tau biomarkers such as p-Tau 181 and p-Tau 217. Featured speaker, Thomas K Karikari, PhD, Assistant Professor of Psychiatry at the University of Pittsburgh, will discuss new data on ultra-sensitive detection of p-Tau 205 and p-Tau 212 as well as the future of blood-based biomarkers in Alzheimer's disease.
TORONTO, Aug. 26, 2025 /PRNewswire/ -- Phosphorylated tau (p-Tau) biomarkers have become a cornerstone of Alzheimer's disease research and diagnosis--but not all p-Tau species offer the same diagnostic or prognostic value. In this webinar, Thomas K Karikari, PhD, Assistant Professor of Psychiatry at the University of Pittsburgh, will explore the scientific rationale and clinical relevance of p-Tau 205 and p-Tau 212, two emerging biomarkers showing promise for improving early detection and disease staging.
Through an in-depth discussion of the latest research, analytical validation data and potential clinical applications, this session will illuminate how p-Tau 205 and p-Tau 212 may offer complementary insights to established biomarkers like p-Tau 181 and p-Tau 217--and help move the field closer to scalable, blood-based Alzheimer's diagnostics.
Whether working in biomarker discovery, translational research or clinical development, this webinar will offer actionable insights into the next wave of neurodegenerative disease biomarkers.
Register for this webinar to learn how p-Tau 205 and p-Tau 212 may advance Alzheimer's disease diagnosis and biomarker precision.
Join Thomas K Karikari, PhD, Assistant Professor of Psychiatry, University of Pittsburgh, for the live webinar on Thursday, September 11, 2025, at 1:00 pm EDT (6:00 pm BST/UK).
For more information, or to register for this event, visit p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer's Disease Research.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/p-tau-205-and-p-tau-212-emerging-biomarkers-for-alzheimers-disease-research-upcoming-webinar-hosted-by-xtalks-302537993.html
SOURCE Xtalks
